Skip to main content
. 2023 May 5;11(5):1371. doi: 10.3390/biomedicines11051371

Figure 2.

Figure 2

TF pathway markers in COVpos patients. Levels of TF concentration (A) and TF activity (B) and TFPI (C) in COVpos (n = 47) and COVneg (n = 36) patients.